Sun Pharmaceuticals Industries consolidated net profit rises 33.77% in the March 2024 quarter

Sales rise 10.14% to Rs 11813.33 crore

Net profit of Sun Pharmaceuticals Industries rose 33.77% to Rs 2654.58 crore in the quarter ended March 2024 as against Rs 1984.47 crore during the previous quarter ended March 2023. Sales rose 10.14% to Rs 11813.33 crore in the quarter ended March 2024 as against Rs 10725.57 crore during the previous quarter ended March 2023.

For the full year,net profit rose 13.01% to Rs 9576.38 crore in the year ended March 2024 as against Rs 8473.58 crore during the previous year ended March 2023. Sales rose 10.35% to Rs 47758.45 crore in the year ended March 2024 as against Rs 43278.87 crore during the previous year ended March 2023.

 

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales11813.3310725.57 10 47758.4543278.87 10 OPM %25.6926.13 -27.2726.91 - PBDT3567.523082.67 16 14138.8512109.31 17 PBT2917.162411.14 21 11582.219579.88 21 NP2654.581984.47 34 9576.388473.58 13

Powered by Capital Market - Live News